Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Truly personalized therapy

× No keyword cloud information.

4 in total

1. Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.

Authors: Ian E Krop; Seock-Ah Im; Carlos Barrios; Hervé Bonnefoi; Julie Gralow; Masakazu Toi; Paul A Ellis; Luca Gianni; Sandra M Swain; Young-Hyuck Im; Michelino De Laurentiis; Zbigniew Nowecki; Chiun-Sheng Huang; Louis Fehrenbacher; Yoshinori Ito; Jigna Shah; Thomas Boulet; Haiying Liu; Harrison Macharia; Peter Trask; Chunyan Song; Eric P Winer; Nadia Harbeck
Journal: J Clin Oncol Date: 2021-12-10 Impact factor: 50.717

2. High throughput screen for the improvement of inducible promoters for tumor microenvironment cues.

Authors: Omri Sharabi; Yariv Greenshpan; Noa Ofir; Aner Ottolenghi; Tamar Levi; Leonid Olender; Zachor Adler-Agmon; Angel Porgador; Roi Gazit
Journal: Sci Rep Date: 2022-05-03 Impact factor: 4.996

3. Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers.

Authors: Juanjuan Gu; Eric C Polley; Judy C Boughey; Robert T Fazzio; Mostafa Fatemi; Azra Alizad
Journal: Ultrasound Med Biol Date: 2021-05-14 Impact factor: 3.694

4. The Current Landscape of Clinical Studies Focusing on Thyroid Cancer: A Comprehensive Analysis of Study Characteristics and Their Publication Status.

Authors: Yihao Liu; Bin Li; Qiuyi Zheng; Jia Xu; Jie Li; Fenghua Lai; Bo Lin; Sui Peng; Weiming Lv; Haipeng Xiao
Journal: Front Endocrinol (Lausanne) Date: 2020-11-20 Impact factor: 5.555

4 in total

Truly personalized therapy - an end to the era of one size fits all.

1. Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.

2. High throughput screen for the improvement of inducible promoters for tumor microenvironment cues.

3. Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers.

4. The Current Landscape of Clinical Studies Focusing on Thyroid Cancer: A Comprehensive Analysis of Study Characteristics and Their Publication Status.